PIRAMAL PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 158 INR | +0.40% |
|
+0.48% | +13.78% |
| May. 14 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
| May. 13 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
Evolution of the average Target Price on Piramal Pharma Limited
Price target over the last 5 years
History of analyst recommendation changes
322ba5114371c21f29bb36889ff842e4.n114rc-1CiIEj4Smqtt6Gf4LOVKSVJHWjRPrKVtq_xw.22k81P3GX31wzrP02L4cKrFEXyH6Y9qD-H6cQCokxzHLNBWapuxhR0v9yQ~b996659e7140b51d01b12879f800e17c
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
158
INR
Average target price
178
INR
Spread / Average Target
+12.67%
High Price Target
190
INR
Spread / Highest target
+20.26%
Low Price Target
170
INR
Spread / Lowest Target
+7.60%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Piramal Pharma Limited
| Jefferies & Co. |
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PPLPHARMA Stock
- Consensus Piramal Pharma Limited
